Physician profile
Michael Ayala
NPI 1275056152
$444.51
in general payments reported to CMS, 2019-2025
12 companies · $85.10 in 2025
The $85.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $76.03 · 2023: $216 · 2024: $67.56 · 2025: $85.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $88.42 | 2023 | Acessa Provu System |
| Coopersurgical, INC. | $65.08 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Intuitive Surgical, INC. | $64.30 | 2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $41.90 | 2025 | Enseal |
| Organon LLC | $34.73 | 2024 | |
| Exact Sciences Corporation | $27.89 | 2025 | The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $26.61 | 2022 | |
| Mayne Pharma Commercial LLC | $26.31 | 2022 | |
| Dysis Medical, INC. | $23.11 | 2022 | |
| Sumitomo Pharma America, INC. | $15.89 | 2023 | Myfembree |
| Pfizer INC. | $15.31 | 2025 | |
| Merck Sharp & Dohme LLC | $14.96 | 2023 | Vaxneuvance, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ayala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.